Latest From Our Blog
Some Fourth-Year Medical Students Lack Proficiency in Detecting Melanomas (Reuters 2/12) According to research presented at the American Academy of Dermatology meeting, some fourth-year medical students are not particularly proficient when it comes to detecting melanomas. In a study in which students were presented with patients complaining about carpal tunnel syndrome and wearing simulated melanomas, […]
Age is no guarantee of wisdom (Archives of Dermatology 12/2010) More than 30 MILLION people use tanning beds in the U.S. each year despite the fact that the World Health Organization has designated tanning beds as cancer causing. Researchers have suggested that the increasing incidence of Melanoma and non-Melanoma skin cancers is due to the […]
(American Journal of Medicine 05/2010) According to recent surveys, only about 13% of women and 16% of men received skin cancer screening Total skin examination by a qualified physician represents a major opportunity – or one lost – to detect early skin cancer such as Melanoma. How often do you think most of us […]
(CNN, EWG 5/11) With the new FDA guidelines on sunscreens, many agencies are advising you to remember that sunscreens alone cannot prevent skin cancer. Don’t forget about staying in the shade, using protective clothing such as wide-brimmed hats and sunglasses with UVA/UVB protection, and trying to avoid sun at the peak hours of 10 […]
(Washington Post 6/11). MEN!!! It seems male patients approaching the ages of 40-60 years feel it is important to keep a youthful look to ensure both social and professional successes, especially in this tight, youthful, and highly competitive job market. IT’S ANOTHER EXAMPLE OF EQUALITY OF THE SEXES.
Although most people are familiar with the word melanoma, and think it is the most lethal skin cancer, the survival rates for the Merkel Cell Carcinoma (MCC) are much worse. It is an uncommon form of skin cancer. A study done in Australia from 1993-2007 showed 64% of MCC alive at 5 years, versus 90% […]
(New York Times 7/11). A combination of factors has discouraged many doctors from carrying Zostavax, the vaccine for shingles. Merck, the manufacturer has also been unable to provide sufficient quantities to even meet modest demands. As a result, intermittent shortages have prevented consistent marketing and have therefore stalled Public Health agencies from informing the public. […]
